RVPH - Reviva Pharmaceuticals GAAP EPS of -$0.44 misses by $0.12
2023-11-14 17:16:18 ET
More on Reviva Pharmaceuticals
- Reviva Pharmaceuticals: Positive Results In Phase 3 But The Stock Is Back Where It Started
- Reviva Pharmaceuticals: A Binary Event Approaches With Results From RECOVER
- Reviva posts late-stage data for schizophrenia candidate
- Seeking Alpha’s Quant Rating on Reviva Pharmaceuticals
- Historical earnings data for Reviva Pharmaceuticals
For further details see:
Reviva Pharmaceuticals GAAP EPS of -$0.44 misses by $0.12